Gara Jalqabaatti › Luukemiya Limfoositiikii Keessummaa › Oregon › Eugene
Qorannoo klinikaalii Luukemiya Limfoositiikii Keessummaa Eugene, OR keessatti
Qorannoo 6 Luukemiya Limfoositiikii Keessummaa f Eugene fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Namoota walitti qabaa jiraSadarkaa 3
- Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Namoota walitti qabaa jiraSadarkaa 3
- Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
Namoota walitti qabaa jiraSadarkaa 3
- Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- Oncology Associates of Oregon, Eugene
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
- Williamette Valley Cancer Institute & Research Center, Eugene
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Namoota walitti qabaa jiraSadarkaa 3
- Willamette Valley Cancer Institute and Research Center /ID# 266326, Eugene
Qorannoo Luukemiya Limfoositiikii Keessummaa magaalota biroo keessatti
- Boston, MAQorannoo 31
- Columbus, OHQorannoo 28
- Durham, NCQorannoo 27
- Washington, DCQorannoo 22
- Seattle, WAQorannoo 20
- Rochester, MNQorannoo 19
- New York City, NYQorannoo 18
- Houston, TXQorannoo 17
- Baldwin Park, CAQorannoo 16
- Milwaukee, WIQorannoo 15
- Cincinnati, OHQorannoo 14
- Chicago, ILQorannoo 14
Qorannoo biroo Eugene keessatti
- Kansara Qara'a Non-Small CellQorannoo 13
- Kansarii OvariiQorannoo 9
- Kansa EndometiriyaaliiQorannoo 8
- Saree OljooQorannoo 7
- Myeloma Baay’eeQorannoo 6
- Kansara MetastatikiiQorannoo 6
- Saree (Gosoota Hunda)Qorannoo 6
- Itti Fayyadama Qorannoo fi AddictionQorannoo 5
- Dhibee QaraQorannoo 5
- Degenereshinii MakulaariiQorannoo 5
- ObesityQorannoo 4
- Kansarii ProstateQorannoo 3
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.